Salary Range:CHF115,500.00 - CHF214,500.00 BandLevel 5 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Join Novartis Internal Audit at the forefront of technology innovation, where you will help safeguard and shape the future of data, Artificial Intelligence, cybersecurity and
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Salary Range:CHF146,300.00 - CHF271,700.00 Job Description SummaryLocation: Basel, Switzerland; #LI-Hybrid 3 days/week in office Internal job title: Head of Phenomics About the Role: The Head of Phenomics will lead strategy and execution for phenomics initiatives that
At Fresenius Medical Care, we are the global leader in kidney care, committed to improving the lives of patients with chronic kidney disease. Our mission is to deliver high-quality, innovative products, services, and care across the
Salary Range:CHF122,500.00 - CHF227,500.00 Job Description SummaryLocation: East Hanover NJ, US or Basel Switzerland. This role will follow a hybrid working model. If based in US, please apply to REQ-10080236 LI-#hybrid The Associate Director, Therapeutic Area
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description SummaryAs a Delivery Lead for Lab Automation & Logistics in Data & Digital (D&D), you will drive the delivery and adoption of cutting-edge automation, orchestration, and AI-enabled solutions across
Join our team as a Verification & Validation Engineer Sentec is a Swiss-American medical device company specializing in respiratory care. Since its founding in 1999 the company utilizes a deep-tech approach that is founded on advanced
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office
Salary Range:CHF122,500.00 - CHF227,500.00 Job Description SummaryAs a Solution Architect in Innovation & Delivery, you are responsible for not only designing and planning, but actively guiding thru execution end-to-end solution architectures that enable scalable, integrated, and
Salary Range:CHF93,800.00 - CHF174,200.00 Job Description SummaryThe Innovation Scout drives early identification and translation of emerging technologies, scientific opportunities, and external innovations into actionable insights and experiments that inform product, platform, and portfolio direction. Acting as
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,